The prognostic value of the suPARnostic(® )ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms

BACKGROUND: High blood levels of soluble urokinase Plasminogen Activator Receptor (suPAR) are associated with poor outcomes in human immunodeficiency-1 (HIV-1) infected individuals. Research on the clinical value of suPAR in HIV-1 infection led to the development of the suPARnostic(® )assay for comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Uffe V, Nielsen, Rikke L, Pedersen, Court, Eugen-Olsen, Jesper
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216028/
https://www.ncbi.nlm.nih.gov/pubmed/18021410
http://dx.doi.org/10.1186/1471-2334-7-134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216028/
https://www.ncbi.nlm.nih.gov/pubmed/18021410
http://dx.doi.org/10.1186/1471-2334-7-134

Ejemplares similares